KIORA PHARMACEUTICALS, INC.

Analyst Reco. Kiora Pharmaceuticals, Inc.

Equities

KPRX

US49721T3095

Real-time Estimate Cboe BZX Other stock markets 09:48:04 2024-05-14 EDT			5-day change	1st Jan Change
0.502 ^USD	-1.51%		+1.82%	-2.35%

05-10	Earnings Flash (KPRX) KIORA PHARMACEUTICALS Posts Q1 Revenue $16M	MT
03-25	Kiora Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

HC Wainwright Adjusts Price Target on Kiora Pharmaceuticals to $2 From $3.50, Maintains Buy Rating	02-09	MT
HC Wainwright Adjusts Kiora Pharmaceuticals' Price Target to $3.50 From $2, Keeps Buy Rating	11-06	MT
HC Wainwright Adjusts Price Target on Kiora Pharmaceuticals to $2 From $7, Keeps Buy Rating	23-08-14	MT
HC Wainwright Raises Kiora Pharmaceuticals' Price Target to $7 From $6, Maintains Buy Rating	23-05-12	MT
Maxim Upgrades Kiora Pharmaceuticals to Buy From Hold, Price Target is $12	23-02-09	MT
Ladenburg Thalmann Reiterates Kiora Pharmaceuticals at Buy With $119 Price Target	23-02-08	MT
HC Wainwright Reiterates Kiora Pharmaceuticals at Buy With $10 Price Target	23-02-08	MT
Ladenburg Thalmann Initiates Kiora Pharmaceuticals at Buy With $6.50 Price Target	22-08-25	MT
Maxim Group Downgrades Kiora Pharmaceuticals to Hold From Buy	22-08-15	MT
HC Wainwright Adjusts Price Target on Kiora Pharmaceuticals to $2.50 From $3, Reiterates Buy Rating	22-07-11	MT
HC Wainwright Adjusts Kiora Pharmaceuticals Price Target to $3 From $5, Maintains Buy Rating	22-04-19	MT
Maxim Starts Kiora Pharmaceuticals at Buy With $2.50 Price Target	22-01-19	MT
EYEGATE PHARMACEUTICALS : HC Wainwright Adjusts Price Target on Eyegate Pharmaceuticals to $11 From $14, Maintains Buy Rating	21-08-16	MT
EYEGATE PHARMACEUTICALS : Alliance Global Securities Adjusts Eyegate Pharmaceuticals PT to $10.75 From $10.25, Maintains Buy Rating	21-05-18	MT
EYEGATE PHARMACEUTICALS : Alliance Global Partners Adjusts Eyegate Pharmaceuticals PT $10.25 From $16.75, Maintains Buy Rating	21-03-31	MT
EYEGATE PHARMACEUTICALS : HC Wainwright Adjusts Eyegate Pharmaceuticals' Price Target to $14 From $10, Keeps at Buy	20-12-22	MT
EYEGATE PHARMACEUTICALS : Alliance Global Partners Adjusts Eyegate Pharmaceuticals PT to $15.50 From $9.50, Maintains Buy Rating	20-12-22	MT
EYEGATE PHARMACEUTICALS : HC Wainwright Adjusts Eyegate Pharmaceuticals' Price Target to $10 From $12, Keeps Buy Rating	20-11-12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW